The objective of this study was to investigate the effect of altering the level of Flii in an aggressive metastatic cSCC cell line (MET-1) to better understand its functional effect on cellular processes critical in cSCC development and progression, including cell division, proliferation, differentiation and Wnt/β-catenin signaling. The gene discussed is FLII; the disease is skin squamous cell carcinoma.